Human testing of oral PMPA for treatment of HIV begins.
D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D004311:Double-Blind Method; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D018579:Patient Selection; D011355:Prodrugs / Q000008:administration & dosage*; D012107:Research Design; D012999:Soman / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014481:United States
D000998:Antiviral Agents; D011355:Prodrugs; C046573:pinacolyl methylphosphonic acid; D012999:Soman